Completed

A Study of LY3303560 in Participants with Mild Cognitive Impairment or Alzheimer's Disease

I8G-MC-LMDD - ClinicalTrials.gov - NCT03019536

This study involves repeated doses of LY3303560 given by injection for 25 weeks. The study will examine how safe repeated doses of LY3303560 are, whether they cause side effects in participants with mild cognitive impairment or Alzheimer's Disease, and how LY3303560 is handled by the body and acts in the body.
How long will I be in the trial?
participation could last up to 18.5 months and include up to 27 visits to the study center.
Email
Completed

A Study of LY3303560 in Participants with Mild Cognitive Impairment or Alzheimer's Disease

I8G-MC-LMDD - ClinicalTrials.gov - NCT03019536

This study involves repeated doses of LY3303560 given by injection for 25 weeks. The study will examine how safe repeated doses of LY3303560 are, whether they cause side effects in participants with mild cognitive impairment or Alzheimer's Disease, and how LY3303560 is handled by the body and acts in the body.
How long will I be in the trial?
participation could last up to 18.5 months and include up to 27 visits to the study center.
Email

Key Requirements

Age :

50+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

50+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Mild Cognitive Impairment, Mild Alzheimer's

What the trial is testing?

interventions example

Could I receive a Placebo?

yes

Enrollment Goal

24

Trial Dates

January 2017 - June 2019

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

50+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Mild Cognitive Impairment, Mild Alzheimer's

What the trial is testing?

interventions example

Could I receive a Placebo?

yes

Enrollment Goal

24

Trial Dates

January 2017 - June 2019

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Resources

Memory, Alzheimer’s Disease, and Research Studies

Memory, Alzheimer’s Disease, and Research Studies

With the help of research study participants, we are learning about aging, memory, and potential new approaches to fighting Alzheimer’s disease.
Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?